Jeanne Fabre
Latham & WatkinsPraised by clients for its ‘exceptional precision’, Latham & Watkins often handles M&A and series financing mandates, acting for medical equipment companies, investors, and medical device clients. The ’outstanding’ Eveline Van Keymeulen leads the team and is recommended for her vast experience in EU regulatory issues, particularly in relation to medical cannabis and hemp-based products. Jeanne Fabre regularly assists clients with market access strategy, advertising compliance, and clinical trial-related matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is structured, responsive and very experienced in life sciences.’
‘Eveline Van Keymeulen is an outstanding lawyer, who provides finely crafted legal advice and whose availability and dedication are highly appreciated. One of the best if not the best lawyer in Europe in life sciences.’
‘The Latham & Watkins healthcare and life sciences practice stands out for its deep industry expertise and cross-disciplinary approach. The team offers a unique blend of regulatory, transactional, and litigation capabilities, allowing them to navigate complex matters with exceptional precision.’
‘The team's understanding of the life sciences sector is remarkable, with an ability to anticipate client needs and adapt strategies accordingly. This practice is particularly skilled at managing challenging regulatory landscapes and negotiating significant market access or M&A transactions, making them a trusted advisor for navigating the industry's nuanced demands.’
‘Eveline Van Keymeulen is truly an exceptional partner, and her expertise makes her stand out distinctly among peers. Her deep knowledge of European and cross-border regulatory frameworks, coupled with her ability to provide practical, business-oriented solutions, has been invaluable. Eveline has a rare skill of making complex regulatory matters comprehensible, which has been particularly helpful when navigating high-stakes scenarios involving product approvals and compliance challenges.’
- ‘What truly sets Eveline Van Keymeulen apart is her dedication to her clients. She is always accessible, ensuring her clients feel supported throughout every stage of their projects. Her thorough understanding of the healthcare and life sciences sector, from clinical trials to post-market obligations, is complemented by her strategic approach.’
Key clients
- Abbott
- AbbVie
- Air Liquide Santé France
- Ardian
- Anne’s Daye
- Argenx
- Astorg Partners
- bioMérieux
- Bridgepoint
- Direct Relief Foundation
- EFPIA
- Eleusis
- Eli Lilly
- Eurazeo
- Euronext
- European Sperm Bank
- GlaxoSmithKline
- GRAIL
- Inari Medical
- Ipsen
- Ironwood Pharmaceuticals
- Les Laboratoires Servier
- Marinus Pharmaceuticals
- MeiraGTX
- Oncohost
- ProPharma Group
- Resilience Care
- ReCor Medical
- Samsung Medison
- Swedish Orphan Biovitrum AB
- Tempus Labs, Inc.
- Veracyte
- Zoī
Work highlights
- Advised Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, on its agreement to acquire 100% of the shares of Sonio SAS, a fetal ultrasound AI software company.
- Advised Boston Scientific on the US$50 series D financing round of TriCares, a MedTech which has operations in France and Germany that develops a breakthrough tricuspid heart valve replacement system.
- Advised Eurazeo in the context of the sale of its stake in D.O.R.C (Dutch Ophthalmic Research Center) to Carl Zeiss Meditec AG.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Eveline Van Keymeulen